A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
Introduction. Due to the growth of laboratory-confirmed cases of pertussis among adolescents and adults, the spread of latent form of disease and the identification of asymptomatic carriage of the pathogen, the need arose to create a new vaccine against B. pertussis. On the basis of N. F. Gamaleya F...
| Päätekijät: | , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | Russian |
| Julkaistu: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-02-01
|
| Sarja: | Разработка и регистрация лекарственных средств |
| Aiheet: | |
| Linkit: | https://www.pharmjournal.ru/jour/article/view/754 |